secwatch / observer
8-K filed June 18, 2026, 4:19 PM ET ticker GDRX CIK 0001809519
other material confidence high sentiment neutral materiality 0.10

GoodRx stockholders elect three Class III directors and ratify KPMG as auditor at 2026 annual meeting

GoodRx Holdings, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

GoodRx Holdings, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-16 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-06-16
Exact text from the filing
Item 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 2,429,055,999 335,716 183,106 0
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

GoodRx Holdings, Inc. shareholders approved Election of three Class III directors at the 2026-06-16 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-06-16
Exact text from the filing
Item 1 — Election of three Class III directors for a term of office expiring on the date of the Annual Meeting of Stockholders to be held in 2029 and until their respective successors have been duly elected and qualified or until their respective earlier death, resignation or removal. Votes FOR Votes WITHHELD Broker Non-Votes Wendy Barnes 2,379,952,868 10,078,860 39,543,093 Ronald E. Bruehlman 2,380,863,641 9,168,087 39,543,093 Gregory Mondre 2,382,474,121 7,557,607 39,543,093
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.95

GoodRx Holdings, Inc. shareholders approved Advisory (non-binding) vote on the compensation of the named executive officers. at the 2026-06-16 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-06-16
Exact text from the filing
Item 3 — Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 2,363,913,370 23,702,520 2,415,838 39,543,093
View on SEC.gov

1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →

GoodRx Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001809519-26-000133
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.